<DOC>
	<DOC>NCT00050609</DOC>
	<brief_summary>The purposes of this study are to determine whether an experimental drug known as tadalafil can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal, bloating, discomfort or pain in the upper abdomen, belching after meals, nausea, vomiting) in diabetic patients, and/or reduce the amount of time the stomach takes to empty the contents of a standard meal. The safety of tadalafil given once daily for 8 weeks in this population will also be studied.</brief_summary>
	<brief_title>Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Diagnosis of diabetes mellitus Delayed gastric emptying 3 month minimum history of chronic upper abdominal discomfort Symptoms of dyspepsia (upset stomach) Major gastrointestinal surgery or medical conditions known to affect gastric motility Irritable Bowl Syndrome Medications known to affect gastric motility Angina treated with nitrates Uncontrolled diabetes mellitus and history of certain heart problems</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>